Inventor · disambiguated record
Brian Kornberg
Also filed as: KORNBERG BRIAN · KORNBERG BRIAN E · KORNBERG BRIAN EDWARD
13 granted patents·4 pending applications·66 citations·filing 1994–2024
90Inventor score
Top patents by PatentIndex Score
17 records- 0187US11292781B2Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2017·Granted Apr 5, 2022·4 cites·40 claims
- 0279US2025188053A1Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0376US5658902AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1994·Granted Aug 19, 1997·16 cites·13 claims
- 0471US2024360084A1Pyrazole and imidazole compounds for inhibition of il-17 and rorgammaREATA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0570US12195443B2Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other usesREATA PHARMACEUTICALS INC·Filed 2022·Granted Jan 14, 2025·0 cites·35 claims
- 0666US6096744ASulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1998·Granted Aug 1, 2000·11 cites·3 claims
- 0763US6642256B2Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonistsWARNER LAMBERT CO·Filed 2001·Granted Nov 4, 2003·2 cites·8 claims
- 0863US6340758B1Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agentsWARNER LAMBERT CO·Filed 1998·Granted Jan 22, 2002·8 cites·2 claims
- 0954US11993574B2Pyrazole and imidazole compounds for inhibition of IL-17 and RORgammaREATA PHARMACEUTICALS INC·Filed 2019·Granted May 28, 2024·0 cites·37 claims
- 1054US5773444AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Jun 30, 1998·5 cites·5 claims
- 1153US5663296AHydroxamate inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1995·Granted Sep 2, 1997·7 cites·11 claims
- 1248US6455698B1Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agentsWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·0 cites·2 claims
- 1348US5654303AAlkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Aug 5, 1997·8 cites·15 claims
- 1446US2005282819A1Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophreniaGRAHAM JAMES M·Filed 2004·Application pending·0 cites
- 1541US5874426ACyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Feb 23, 1999·4 cites·9 claims
- 1638US6110911ACyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1999·Granted Aug 29, 2000·1 cites·1 claims
- 1736US2004138230A1Heterocyclic substituted piperazines for the treatment of schizophreniaFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Kornberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →